Table 3

Summary of primary outcome data at baseline and 4 and 12 months follow-up and analysis of between group differences in total weekly minutes (recorded in bouts and no bouts) at 12 months

Baseline4-month follow-up12-month follow-upBetween group difference at 12 months*
Mean (95% CI) P value
Control (n=201) Mean (SD) Median (IQR)Intervention (n=207) Mean (SD) Median (IQR)Control
(n=128) Mean (SD) Median (IQR)
Intervention
(n=109) Mean (SD) Median (IQR)
Control
(n=133) Mean (SD) Median (IQR)
Intervention
(n=110) Mean (SD), Median (IQR)
Total weekly minutes of MVPA in ≥10 min bouts30.2 (105.8)
0 (0–23.3)
31.8 (53.7)
7.5 (0–41.1)
30.9 (64.5)
0 (0–45.9)
38.4 (74.5)
0 (0–49.4)
18.7 (37.4)
0 (0–19.8)
35.4 (78.3)
0 (0–40.4)
11.8 (−2.1 to 26.0), 0.10
Total weekly minutes of MVPA†319.2 (249.2)
264.6 (147.0–395.5)
371.7 (251.3)
309.4 (196.7–490.7)
324.1 (264.6)
257.6 (151.2–375.2)
408.1 (251.3)
340.2 (231.7–521.5)
298.2 (210.7)
252.0 (144.2–420.0)
363.3 (256.2)
303.8 (186.9–469.0)
13.7 (−26.8 to 54.2), 0.51
  • Data from participants included as per primary analysis with 232 participants providing data at baseline and 12 months, and of these, from the 172 who provided data at 4 months.

  • *Adjusted for baseline MVPA, age, gender, site and minimisation variables.

  • †Unbouted minutes.

  • MVPA, moderate-to-vigorous physical activity.